Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.
2.

Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.

Robinson N, Saudan C, Sottas PE, Mangin P, Saugy M.

J Pharm Biomed Anal. 2007 Jan 4;43(1):270-6. Epub 2006 Aug 1.

PMID:
16884883
3.

Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.

Shahzad K, Kim DH, Kang MJ.

Clin Biochem. 2007 Nov;40(16-17):1259-65. Epub 2007 Jul 27.

PMID:
17884034
4.

Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.

Reis MF, Aniceto P, Aguiar P, Simão F, Segurado S.

Int J Hyg Environ Health. 2007 May;210(3-4):419-27. Epub 2007 Mar 1.

PMID:
17336148
5.

Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.

Abellan R, Ventura R, Pichini S, Remacha AF, Pascual JA, Pacifici R, Di Giovannandrea R, Zuccaro P, Segura J.

J Pharm Biomed Anal. 2004 Sep 3;35(5):1169-77.

PMID:
15336362
6.

New decision limits and quality-control material for detecting human chorionic gonadotropin misuse in sports.

Laidler P, Cowan DA, Hider RC, Kicman AT.

Clin Chem. 1994 Jul;40(7 Pt 1):1306-11.

7.

Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control.

Stenman UH, Unkila-Kallio L, Korhonen J, Alfthan H.

Clin Chem. 1997 Jul;43(7):1293-8. Review.

8.

Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.

Handelsman DJ, Goebel C, Idan A, Jimenez M, Trout G, Kazlauskas R.

Clin Endocrinol (Oxf). 2009 Sep;71(3):417-28. doi: 10.1111/j.1365-2265.2008.03516.x. Epub 2008 Dec 18.

PMID:
19170708
9.

Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.

Cole LA, Shahabi S, Oz UA, Rinne KM, Omrani A, Bahado-Singh RO, Mahoney MJ.

Prenat Diagn. 1999 Apr;19(4):351-9.

PMID:
10327141
10.

Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.

Abellan R, Ventura R, Palmi I, di Carlo S, Bacosi A, Bellver M, Olive R, Pascual JA, Pacifici R, Segura J, Zuccaro P, Pichini S.

J Pharm Biomed Anal. 2008 Nov 4;48(3):844-52. doi: 10.1016/j.jpba.2008.05.037. Epub 2008 Jun 7.

PMID:
18617352
11.

Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes.

Abellan R, Ventura R, Palmi I, di Carlo S, di Giovannandrea R, Bellver M, Olive R, Pascual JA, Pacifici R, Segura J, Zuccaro P, Pichini S.

J Pharm Biomed Anal. 2009 Apr 5;49(3):793-9. doi: 10.1016/j.jpba.2008.12.037. Epub 2009 Jan 8.

PMID:
19181472
12.

Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.

Strahm E, Marques-Vidal P, Pralong F, Dvorak J, Saugy M, Baume N.

Forensic Sci Int. 2011 Dec 10;213(1-3):62-72. doi: 10.1016/j.forsciint.2011.07.002. Epub 2011 Jul 27.

PMID:
21798680
13.

Urinary human chorionic gonadotropin isoform concentrations in doping control samples.

Butch AW, Woldemariam GA.

Drug Test Anal. 2016 Nov;8(11-12):1147-1151. doi: 10.1002/dta.2061. Epub 2016 Sep 29.

PMID:
27594536
14.

Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis.

Lund H, Snilsberg AH, Halvorsen TG, Hemmersbach P, Reubsaet L.

Bioanalysis. 2013 Mar;5(5):623-30. doi: 10.4155/bio.13.8.

PMID:
23425277
15.

Loss of human chorionic gonadotropin in urine during storage at -20°C.

Lempiäinen A, Hotakainen K, Alfthan H, Stenman UH.

Clin Chim Acta. 2012 Jan 18;413(1-2):232-6. doi: 10.1016/j.cca.2011.09.038. Epub 2011 Oct 4.

PMID:
21988940
17.

Stability of immunoreactive beta-core fragment of hCG.

de Medeiros SF, Amato F, Norman RJ.

Obstet Gynecol. 1991 Jan;77(1):53-9.

PMID:
1984227
18.

Validation of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas.

González-Sánchez V, Moreno-Pérez O, Pellicer PS, Sánchez-Ortiga R, Guerra RA, Dot MM, Alfonso AM.

Ann Clin Biochem. 2011 Sep;48(Pt 5):433-7. doi: 10.1258/acb.2010.010074. Epub 2011 Jun 30.

PMID:
21719508
19.

Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.

Kuuranne T, Ahola L, Pussinen C, Leinonen A.

Drug Test Anal. 2013 Aug;5(8):614-8. doi: 10.1002/dta.1449. Epub 2013 Jan 10.

PMID:
23303576
20.

Detection of human chorionic gonadotrophin misuse in sports.

Delbeke FT, Van Eenoo P, De Backer P.

Int J Sports Med. 1998 May;19(4):287-90.

PMID:
9657371

Supplemental Content

Support Center